Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net earnings	$ 3,899,000,000	$ 4,764,000,000	$ 7,209,000,000
Less: earnings from discontinued operations, net of income taxes	0	(543,000,000)	(881,000,000)
Net earnings from continuing operations	3,899,000,000	4,221,000,000	6,328,000,000
Noncash items:
Depreciation	721,000,000	675,000,000	698,000,000
Amortization of intangible assets	1,631,000,000	1,491,000,000	1,434,000,000
Amortization of acquisition-related inventory fair value step-up	25,000,000	8,000,000	0
Stock-based compensation expense	288,000,000	306,000,000	295,000,000
Investment losses	57,000,000	182,000,000	271,000,000
Impairment charges	265,000,000	77,000,000	0
Change in deferred income taxes	(483,000,000)	(1,204,000,000)	(582,000,000)
Change in trade accounts receivable, net	331,000,000	322,000,000	(389,000,000)
Change in inventories	147,000,000	185,000,000	(448,000,000)
Change in trade accounts payable	19,000,000	(149,000,000)	(18,000,000)
Change in prepaid expenses and other assets	274,000,000	419,000,000	(73,000,000)
Change in accrued expenses and other liabilities	(486,000,000)	(43,000,000)	97,000,000
Total operating cash provided by continuing operations	6,688,000,000	6,490,000,000	7,613,000,000
Total operating cash provided by discontinued operations	0	674,000,000	906,000,000
Net cash provided by operating activities	6,688,000,000	7,164,000,000	8,519,000,000
Cash flows from investing activities:
Cash paid for acquisitions	(558,000,000)	(5,610,000,000)	(582,000,000)
Payments for additions to property, plant and equipment	(1,392,000,000)	(1,383,000,000)	(1,118,000,000)
Proceeds from sales of property, plant and equipment	13,000,000	12,000,000	9,000,000
Payments for purchases of investments	(331,000,000)	(172,000,000)	(523,000,000)
Proceeds from sales of investments	253,000,000	61,000,000	18,000,000
All other investing activities	34,000,000	44,000,000	51,000,000
Total cash used in investing activities from continuing operations	(1,981,000,000)	(7,048,000,000)	(2,145,000,000)
Total investing cash used in discontinued operations	0	(33,000,000)	(89,000,000)
Net cash used in investing activities	(1,981,000,000)	(7,081,000,000)	(2,234,000,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock in connection with stock-based compensation	162,000,000	68,000,000	31,000,000
Payment of dividends	(768,000,000)	(821,000,000)	(818,000,000)
Net proceeds from (repayments of) borrowings (maturities of 90 days or less)	5,000,000	(1,006,000,000)	(723,000,000)
Repayments of borrowings (maturities longer than 90 days)	(1,674,000,000)	(620,000,000)	(965,000,000)
Distribution from discontinued operations	0	2,600,000,000	0
Payments for repurchase of common stock	(5,979,000,000)	0	0
All other financing activities	(131,000,000)	(67,000,000)	(95,000,000)
Net cash (used in) provided by financing activities for continuing operations	(8,385,000,000)	154,000,000	(2,570,000,000)
Cash distributions to Veralto Corporation, net	0	(427,000,000)	0
Net cash used in financing activities	(8,385,000,000)	(273,000,000)	(2,570,000,000)
Effect of exchange rate changes on cash and equivalents	(108,000,000)	59,000,000	(306,000,000)
Net change in cash and equivalents	(3,786,000,000)	(131,000,000)	3,409,000,000
Beginning balance of cash and equivalents	5,864,000,000	5,995,000,000	2,586,000,000
Ending balance of cash and equivalents	2,078,000,000	5,864,000,000	5,995,000,000
Supplemental disclosure:
Distribution of noncash net assets to Veralto Corporation	$ 0	$ (1,674,000,000)	$ 0